Patent · US Active

G immunoglobulin used against anthrax toxins

US9012608B2 · kind B2 · utility

0Cited by
0References
15Claims
0Family size

Assignees

Inventors

Key dates

Filing dateNov 28, 2008
Grant dateApr 21, 2015
Priority date—
Expiry dateMar 20, 2030

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/92
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

An immunoglobulin of the G class (IgG) directed against the protective antigen (PA) of the anthrax toxin, includes:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.